Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey.


Journal

American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854

Informations de publication

Date de publication:
12 2022
Historique:
received: 23 12 2021
revised: 19 02 2022
accepted: 21 02 2022
pubmed: 10 3 2022
medline: 7 12 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

Because central line-associated bloodstream infections (CLABSIs) are a significant complication of central venous access, it is critical to prevent CLABSIs through the use of central line bundles. The purpose of this study was to take a snapshot of central venous access bundles in various countries. The participants in intensive care units (ICUs) completed a questionnaire that included information about the health center, infection control procedures, and central line maintenance. The countries were divided into 2 groups: those with a low or low-middle income and those with an upper-middle or high income. Forty-three participants from 22 countries (46 hospitals, 85 ICUs) responded to the survey. Eight (17.4%) hospitals had no surveillance system for CLABSI. Approximately 7.1 % (n = 6) ICUs had no CLABSI bundle. Twenty ICUs (23.5%) had no dedicated checklist. The percentage of using ultrasonography during catheter insertion, transparent semi-permeable dressings, needleless connectors and single-use sterile pre-filled ready to use 0.9% NaCl were significantly higher in countries with higher and middle-higher income (P < .05). Our study demonstrated that there are significant differences in the central line bundles between low/low-middle income countries and upper-middle/high-income countries. Additional measures should be taken to address inequity in the management of vascular access in resource-limited countries.

Sections du résumé

BACKGROUND
Because central line-associated bloodstream infections (CLABSIs) are a significant complication of central venous access, it is critical to prevent CLABSIs through the use of central line bundles. The purpose of this study was to take a snapshot of central venous access bundles in various countries.
METHODS
The participants in intensive care units (ICUs) completed a questionnaire that included information about the health center, infection control procedures, and central line maintenance. The countries were divided into 2 groups: those with a low or low-middle income and those with an upper-middle or high income.
RESULTS
Forty-three participants from 22 countries (46 hospitals, 85 ICUs) responded to the survey. Eight (17.4%) hospitals had no surveillance system for CLABSI. Approximately 7.1 % (n = 6) ICUs had no CLABSI bundle. Twenty ICUs (23.5%) had no dedicated checklist. The percentage of using ultrasonography during catheter insertion, transparent semi-permeable dressings, needleless connectors and single-use sterile pre-filled ready to use 0.9% NaCl were significantly higher in countries with higher and middle-higher income (P < .05).
CONCLUSIONS
Our study demonstrated that there are significant differences in the central line bundles between low/low-middle income countries and upper-middle/high-income countries. Additional measures should be taken to address inequity in the management of vascular access in resource-limited countries.

Identifiants

pubmed: 35263612
pii: S0196-6553(22)00138-9
doi: 10.1016/j.ajic.2022.02.031
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1327-1332

Informations de copyright

Copyright © 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Ilker Devrim (I)

Pediatric Infectious Diseases Department, Dr. Behçet Uz Children's Hospital, Izmir, Türkiye. Electronic address: ilkerdevrim2003@yahoo.com.

Hakan Erdem (H)

Department of Infectious Diseases, Bahrain Oncology Center, King Hamad University Hospital, Busaiteen, Bahrain.

Amani El-Kholy (A)

Department of Clinical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.

Abdullah Almohaizeie (A)

Pharmaceutical Care Division, King Faisal Specialist Hospital Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Mateja Logar (M)

Department of Infectious Diseases, UMC Ljubljana, Ljubljana, Slovenia.

Bilal Ahmad Rahimi (BA)

Department of Infectious Diseases, Kandahar University Medical Faculty, Teaching Hospital, Kandahar, Afghanistan.

Fatma Amer (F)

Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Sevil Alkan-Ceviker (S)

Department of Infectious Diseases and Clinical Microbiology, Onsekiz Mart University, Medical Faculty Hospital, Canakkale, Türkiye.

Meliha Cagla Sonmezer (MC)

Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, School of Medicine, Ankara, Türkiye.

Maya Belitova (M)

Department of Anesthesiology and Intensive Care, University Hospital "Queen Giovanna"-ISUL, EAD, Sofia, Bulgaria.

Jamal Wadi Al-Ramahi (JW)

Department of Infectious Diseases, School of Medicine, The University of Jordan, Amman, Jordan.

Natalia Pshenichnaya (N)

Central Research Institute of Epidemiology, Moscow, Russia.

Maha Ali Gad (MA)

Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Egypt.

Lurdes Santos (L)

Infectious Diseases Intensive Care Unit, Centro Hospitalar Universitário de São João, Porto, Portugal.

Reham Khedr (R)

Department of Pediatric Oncology, National Cancer Institute - Cairo University/Children Cancer Hospital Egypt, Cairo, Egypt.

Abdullahi Nur Hassan (AN)

Department of Infectious Diseases and Clinical Microbiology, Algomed Hospital, Adana, Türkiye.

Elif Boncuoglu (E)

Pediatric Infectious Diseases Department, Dr. Behçet Uz Children's Hospital, Izmir, Türkiye.

Andrea Cortegiani (A)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo and Department of Anesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy.

Andrea Marino (A)

Department of Infectious Diseases, Garibaldi Nesima Hospital, Catania, Italy.

Anna Liskova (A)

Hospital Nitra, St. Elisabeth University of Health Care and Social Work, Bratislava, Slovak Republic.

Atousa Hakamifard (A)

Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Corneliu Petru Popescu (CP)

Dr. Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.

Mumtaz Ali Khan (MA)

National Institute of Health, Islamabad, Pakistan.

Ralitsa Marinova (R)

Military Medical Academy, Sofia, Bulgaria.

Nikolaj Petrov (N)

Military Medical Academy, Sofia, Bulgaria.

Emmanuel Nsutebu (E)

Infectious Diseases Division, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.

Ghaydaa Shehata (G)

Department of Neurology, Assiut University, Assiut, Egypt.

Hamed Azhdari Tehrani (HA)

Department of Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Handan Alay (H)

Department of Infectious Diseases and Clinical Microbiology, Ataturk University, Faculty of Medicine, Erzurum, Türkiye.

Ivana Mareković (I)

Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb, Croatia.

Joanna Zajkowska (J)

University Teaching Hospital, Bialystok, Poland.

Aidos Konkayev (A)

Institution of Trauma and Orthopedics, Astana Medical University, Nur-Sultan, Kazakhstan.

Manar Ezzelarab Ramadan (ME)

Medical Parasitology, Faculty of Medicine, Suez university, Suez, Egypt.

Michele Pagani (M)

UOC Anestesia e Rianimazione 1, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.

Hasan Agin (H)

Pediatric Intensive Care Unit, Dr. Behçet Uz Children's Hospital, Izmir, Türkiye.

Pierre Tattevin (P)

Department of Infectious and Tropical Diseases, University Hospital of Pontchaillou, Rennes, France.

Rehab El-Sokkary (R)

Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Rezaul Karim Ripon (RK)

Department of Public Health and Informatics, Jahangirnagar University, Bangladesh.

Ricardo Fernandez (R)

Hospital Municipal de San Juan, San Juan, Puerto Rico.

Rosa Fontana Del Vecchio (RFD)

Infectious Diseases Unit, Umberto I Hospital, Siracusa, Italy.

Simona Daniela Popescu (SD)

Elias Emergency University Hospital, Bucharest, Romania.

Souha Kanj (S)

American University of Beirut Medical Center, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH